NDC 58602-714-03 - Guaifenesin and Dextromethorphan HBr
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58602-714
- Requested NDC
- 58602-714-03
- Package NDCs from labels
- 58602-714-05, 58602-714-73, 58602-714-09, 58602-714-12, 58602-714-66, 58602-714-15, 58602-714-03, 58602-714-67, 58602-714-08, 58602-714-07
- Manufacturer
- Sportpharm LLC
- Effective date
- 2026-02-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Guaifenesin and Dextromethorphan HBr - Sportpharm LLC | Sportpharm LLC | 2026-02-18 | HUMAN OTC DRUG LABEL |
| Guaifenesin and Dextromethorphan HBr - Aurohealth LLC | Aurobindo Pharma Limited | Aurohealth LLC | Aurobindo Pharma Limited | 2024-10-03 | Human OTC Drug Label |
| Drug Facts | Preferred Pharmaceuticals Inc. | 2020-07-28 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58602-714-03 | Guaifenesin and Dextromethorphan HBr | 10 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 10 | 12 | |
| 58602-714-05 | Guaifenesin and Dextromethorphan HBr | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 12 | |
| 58602-714-05 | Guaifenesin and Dextromethorphan HBr | 14 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 14 | 12 | |
| 58602-714-07 | Guaifenesin and Dextromethorphan HBr | 6 in 1 CARTON | TABLET, EXTENDED RELEASE | 6 | 12 | |
| 58602-714-08 | Guaifenesin and Dextromethorphan HBr | 4 in 1 CARTON | TABLET, EXTENDED RELEASE | 4 | 12 | |
| 58602-714-09 | Guaifenesin and Dextromethorphan HBr | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 12 | |
| 58602-714-09 | Guaifenesin and Dextromethorphan HBr | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 12 | |
| 58602-714-12 | Guaifenesin and Dextromethorphan HBr | 40 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 40 | 12 | |
| 58602-714-12 | Guaifenesin and Dextromethorphan HBr | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 12 | |
| 58602-714-15 | Guaifenesin and Dextromethorphan HBr | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 12 | |
| 58602-714-15 | Guaifenesin and Dextromethorphan HBr | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 12 | |
| 58602-714-66 | Guaifenesin and Dextromethorphan HBr | 58 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 58 | 12 | |
| 58602-714-66 | Guaifenesin and Dextromethorphan HBr | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 12 | |
| 58602-714-67 | Guaifenesin and Dextromethorphan HBr | 2 in 1 CARTON | TABLET, EXTENDED RELEASE | 2 | 12 | |
| 58602-714-73 | Guaifenesin and Dextromethorphan HBr | 1 in 1 CARTON | TABLET, EXTENDED RELEASE | 1 | 12 | |
| 58602-714-73 | Guaifenesin and Dextromethorphan HBr | 20 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 20 | 12 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 58602-714-67 | EA - Each | 58602-714 | e9aea7b8-ce9e-461f-9e44-2cf997b74be7 | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Desresfriol-DX Softgels | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | OPMX LLC. | ff5e0e0f-bfd2-b02b-e053-6394a90afe8a | 2026-11-04 | Warnings | 9D2RTI9KYH |
| Tenalif Children | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05cd9513-1a42-e990-e063-6294a90a57df | 2026-11-04 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Rompe Tos X Children | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05cc932d-b412-0710-e063-6394a90a87f6 | 2026-11-04 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Rompe Tos X Adults | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05abb2db-d22e-90b5-e063-6294a90ace3f | 2026-11-04 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Tenalif Multi Symptom Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05cd94e7-1808-3bb3-e063-6294a90a4140 | 2026-11-04 | Warnings | 9D2RTI9KYH 495W7451VQ |
| tabcin NIGHT | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | 0b3ed2bb-88ed-699e-e063-6394a90ac023 | 2026-11-04 | Warnings | 9D2RTI9KYH |
| Histiacil Cough | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | OPMX LLC | 7ca99ad2-5127-4a33-bfc6-7c2f596a2b25 | 2026-11-04 | Warnings | 9D2RTI9KYH 495W7451VQ |
| DEXTROMETHORPHAN HBR, GUAIFENESIN | DEXTROMETHORPHAN HBR, GUAIFENESIN | OPMX LLC | 9a16e7f3-78aa-0b01-e053-2a95a90ab19c | 2026-11-04 | Warnings | 9D2RTI9KYH 495W7451VQ |
| Ampigrin Ultra Forte Night | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | e11e71c3-fe7c-77c7-e053-2995a90a34b2 | 2026-11-04 | Warnings | 9D2RTI9KYH |
| Nitecin | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | dfb56532-6f72-1e4d-e053-2a95a90a1c05 | 2026-11-04 | Warnings | 9D2RTI9KYH |
| Pentrexcilina Night Time | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | e11e5c17-28f2-7186-e053-2995a90a51f6 | 2026-11-04 | Warnings | 9D2RTI9KYH |
| Viro Flu PM Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | e1553da8-3a89-e258-e053-2a95a90a4725 | 2026-11-04 | Warnings | 9D2RTI9KYH |
| Activcin | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | OPMX LLC. | e06a4d72-cc8d-fd9d-e053-2995a90a7a76 | 2026-11-04 | Warnings | 9D2RTI9KYH |
| Maximum Strength Severe Congestion and Cough | DEXTROMETHORPHAN HBR, GUAIFENESIN, AND PHENYLEPHRINE HCL | SAFEWAY | 013b94a1-26c7-4371-981a-d1b9d7fd1c98 | 2026-11-03 | Warnings | 9D2RTI9KYH 495W7451VQ |
| DM Max | DEXTROMETHORPHAN HBR, GUAIFENESIN | Walgreen Company | 78edeb7a-4712-4f04-9d76-d5b2d20ce76d | 2026-11-03 | Warnings | 9D2RTI9KYH 495W7451VQ |
| RoboCough | DEXTROMETHORPHAN HBR | DXM Pharmacuetical, Inc. | 32fa7a09-8624-44c1-b9e4-8a8f0594292b | 2026-11-03 | Warnings | 9D2RTI9KYH |
| VICKS FORMULA 44DM NIGHTTIME COUGH and COLD | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, CHLORPHENIRAMINE MALEATE | Procter & Gamble Manufacturing Company | 05414779-f61d-8fa7-e063-6394a90aa034 | 2026-11-03 | Warnings | 9D2RTI9KYH |
| MULTI-SYMPTOM COLD | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Family Dollar Services Inc | b1fae7cc-4033-44bc-aa7c-ca3ceea51c7d | 2026-11-03 | Warnings | 9D2RTI9KYH 495W7451VQ |
| LoHist DM | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDE | Larken Laboratories, Inc. | 29730dab-fa09-4351-9b36-0359ba4f7744 | 2026-11-02 | Warnings | 9D2RTI9KYH |
| EndaCof DM | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HYDROCHLORIDE | Larken Laboratories, Inc. | c68ea55a-8b9a-4a70-8b5c-1a2736651813 | 2026-11-02 | Warnings | 9D2RTI9KYH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.